Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker IMVT
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | Atul Pande Director | IMVT Immunovant, Inc. | Sale | 3,000 | $36.00 | $108.0K Sale | Form 4 ↗ |
| Oct 28, 2026 | Tiago Girao Chief Financial Officer | IMVT Immunovant, Inc. | Sale | 6,606 | $28.50 | $188.3K Sale | Form 4 ↗ |
| Oct 21, 2026 | Jay S. Stout Chief Technology Officer | IMVT Immunovant, Inc. | Sale | 2,595 | $28.94 | $75.1K Sale | Form 4 ↗ |
| Sep 23, 2026 | Christopher Van Tuyl Chief Legal Officer | IMVT Immunovant, Inc. | Sale | 2,846 | $36.36 | $103.5K Sale | Form 4 ↗ |
| Aug 28, 2026 | Atul Pande Director | IMVT Immunovant, Inc. | Sale | 1,500 | $43.27 | $64.9K Sale | Form 4 ↗ |
| Aug 20, 2026 | Gloria Melanie Chief Operating Officer | IMVT Immunovant, Inc. | Sale | 3,056 | $44.16 | $135.0K Sale | Form 4 ↗ |
| Jul 24, 2026 | Atul Pande Director | IMVT Immunovant, Inc. | Sale | 1,500 | $39.80 | $59.7K Sale | Form 4 ↗ |
| Jul 23, 2026 | Jay S. Stout Chief Technology Officer | IMVT Immunovant, Inc. | Sale | 2,857 | $38.69 | $110.5K Sale | Form 4 ↗ |
| Jul 23, 2026 | Tiago Girao Chief Financial Officer | IMVT Immunovant, Inc. | Sale | 6,798 | $38.69 | $263.0K Sale | Form 4 ↗ |
| Jul 8, 2026 | Gloria Melanie Chief Operating Officer | IMVT Immunovant, Inc. | Sale | 106 | $39.99 | $4,239 Sale | Form 4 ↗ |
| Jul 8, 2026 | Gloria Melanie Chief Operating Officer | IMVT Immunovant, Inc. | Sale | 1,930 | $39.53 | $76.3K Sale | Form 4 ↗ |
| Jul 8, 2026 | Christopher Van Tuyl Chief Legal Officer | IMVT Immunovant, Inc. | Sale | 63 | $39.99 | $2,519 Sale | Form 4 ↗ |
| Jul 8, 2026 | Christopher Van Tuyl Chief Legal Officer | IMVT Immunovant, Inc. | Sale | 1,143 | $39.53 | $45.2K Sale | Form 4 ↗ |
| Jul 8, 2026 | Jay S. Stout Chief Technology Officer | IMVT Immunovant, Inc. | Sale | 77 | $39.99 | $3,079 Sale | Form 4 ↗ |
| Jul 8, 2026 | Jay S. Stout Chief Technology Officer | IMVT Immunovant, Inc. | Sale | 1,399 | $39.53 | $55.3K Sale | Form 4 ↗ |
| Jul 8, 2026 | Jay S. Stout Chief Technology Officer | IMVT Immunovant, Inc. | Sale | 105 | $39.99 | $4,199 Sale | Form 4 ↗ |
| Jul 8, 2026 | Jay S. Stout Chief Technology Officer | IMVT Immunovant, Inc. | Sale | 1,906 | $39.53 | $75.3K Sale | Form 4 ↗ |
| Jul 2, 2026 | Eric Venker Chief Executive Officer, Director | IMVT Immunovant, Inc. | Sale | 3,092 | $38.48 | $119.0K Sale | Form 4 ↗ |
| Jun 26, 2026 | Gloria Melanie Chief Operating Officer | IMVT Immunovant, Inc. | Sale | 2,966 | $38.95 | $115.5K Sale | Form 4 ↗ |
| Jun 26, 2026 | Gloria Melanie Chief Operating Officer | IMVT Immunovant, Inc. | Sale | 14,748 | $38.18 | $563.1K Sale | Form 4 ↗ |
| Jun 26, 2026 | Jay S. Stout Chief Technology Officer | IMVT Immunovant, Inc. | Sale | 6,723 | $38.94 | $261.8K Sale | Form 4 ↗ |
| Jun 26, 2026 | Jay S. Stout Chief Technology Officer | IMVT Immunovant, Inc. | Sale | 33,277 | $38.18 | $1.3M Sale | Form 4 ↗ |
| Jun 26, 2026 | Christopher Van Tuyl Chief Legal Officer | IMVT Immunovant, Inc. | Sale | 2,842 | $38.96 | $110.7K Sale | Form 4 ↗ |
| Jun 26, 2026 | Christopher Van Tuyl Chief Legal Officer | IMVT Immunovant, Inc. | Sale | 14,982 | $38.19 | $572.2K Sale | Form 4 ↗ |
| Jun 26, 2026 | Tiago Girao Chief Financial Officer | IMVT Immunovant, Inc. | Sale | 10,000 | $38.46 | $384.6K Sale | Form 4 ↗ |
| Jun 26, 2026 | Atul Pande Director | IMVT Immunovant, Inc. | Sale | 1,500 | $38.01 | $57.0K Sale | Form 4 ↗ |
| Jun 18, 2026 | Christopher Van Tuyl Chief Legal Officer | IMVT Immunovant, Inc. | Sale | 2,634 | $35.39 | $93.2K Sale | Form 4 ↗ |
| Jun 15, 2026 | Atul Pande Director | IMVT Immunovant, Inc. | Sale | 1,500 | $34.02 | $51.0K Sale | Form 4 ↗ |
| May 28, 2026 | Andrew J. Fromkin Director | IMVT Immunovant, Inc. | Sale | 210,468 | $33.56 | $7.1M Sale | Form 4 ↗ |
| May 28, 2026 | Andrew J. Fromkin Director | IMVT Immunovant, Inc. | Sale | 11,483 | $32.64 | $374.8K Sale | Form 4 ↗ |
| May 20, 2026 | Gloria Melanie Chief Operating Officer | IMVT Immunovant, Inc. | Sale | 1,698 | $32.95 | $55.9K Sale | Form 4 ↗ |
| May 20, 2026 | Gloria Melanie Chief Operating Officer | IMVT Immunovant, Inc. | Sale | 1,168 | $32.15 | $37.6K Sale | Form 4 ↗ |
| May 20, 2026 | Gloria Melanie Chief Operating Officer | IMVT Immunovant, Inc. | Sale | 249 | $30.41 | $7,572 Sale | Form 4 ↗ |
| May 20, 2026 | Atul Pande Director | IMVT Immunovant, Inc. | Sale | 6,000 | $32.00 | $192.0K Sale | Form 4 ↗ |
| May 1, 2026 | Robert Graham Susman Director | IMVT Immunovant, Inc. | Sale | 2,502 | $27.17 | $68.0K Sale | Form 4 ↗ |
| Apr 23, 2026 | Tiago Girao Chief Financial Officer | IMVT Immunovant, Inc. | Sale | 25,760 | $29.62 | $763.0K Sale | Form 4 ↗ |
| Apr 23, 2026 | Jay S. Stout Chief Technology Officer | IMVT Immunovant, Inc. | Sale | 2,754 | $29.62 | $81.6K Sale | Form 4 ↗ |
| Apr 8, 2026 | Gloria Melanie Chief Operating Officer | IMVT Immunovant, Inc. | Sale | 8,722 | $24.83 | $216.6K Sale | Form 4 ↗ |
| Apr 8, 2026 | Christopher Van Tuyl Chief Legal Officer | IMVT Immunovant, Inc. | Sale | 5,165 | $24.83 | $128.2K Sale | Form 4 ↗ |
| Apr 8, 2026 | Jay S. Stout Chief Technology Officer | IMVT Immunovant, Inc. | Sale | 1,518 | $24.83 | $37.7K Sale | Form 4 ↗ |
| Apr 8, 2026 | Jay S. Stout Chief Technology Officer | IMVT Immunovant, Inc. | Sale | 8,614 | $24.83 | $213.9K Sale | Form 4 ↗ |
| Apr 2, 2026 | Eric Venker Chief Executive Officer, Director | IMVT Immunovant, Inc. | Sale | 1,409 | $24.60 | $34.7K Sale | Form 4 ↗ |
| Apr 2, 2026 | Eric Venker Chief Executive Officer, Director | IMVT Immunovant, Inc. | Sale | 12,820 | $24.04 | $308.2K Sale | Form 4 ↗ |
| Mar 18, 2026 | Christopher Van Tuyl Chief Legal Officer | IMVT Immunovant, Inc. | Sale | 2,877 | $24.97 | $71.8K Sale | Form 4 ↗ |
| Feb 25, 2026 | Gloria Melanie Chief Operating Officer | IMVT Immunovant, Inc. | Sale | 942 | $28.90 | $27.2K Sale | Form 4 ↗ |
| Feb 25, 2026 | Gloria Melanie Chief Operating Officer | IMVT Immunovant, Inc. | Sale | 859 | $28.16 | $24.2K Sale | Form 4 ↗ |
| Feb 25, 2026 | Gloria Melanie Chief Operating Officer | IMVT Immunovant, Inc. | Sale | 1,437 | $26.98 | $38.8K Sale | Form 4 ↗ |
| Jan 21, 2026 | Jay S. Stout Chief Technology Officer | IMVT Immunovant, Inc. | Sale | 1,977 | $26.03 | $51.5K Sale | Form 4 ↗ |
| Jan 7, 2026 | Jay S. Stout Chief Technology Officer | IMVT Immunovant, Inc. | Sale | 55 | $26.92 | $1,481 Sale | Form 4 ↗ |
| Jan 7, 2026 | Jay S. Stout Chief Technology Officer | IMVT Immunovant, Inc. | Sale | 1,148 | $26.51 | $30.4K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 4:41 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances